Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn

Creating or investing in a Spin-out Company

RCSI welcomes entrepreneurs who may be interested in working with us to develop a spin-out company.

Technologies available for license can be seen here, if you would like to discuss any of these technologies please contact Aoife Gallagher at the Office of Research and Innovation (ORI),

RCSI researchers may be interested in exploring the option of commercialising your technology or invention through the creation of a new company. This option may best suited to only some inventions or technologies, if you would like to discuss this option further please contact us. The team within the ORI will support the establishment and development of a spin-out company and facilitate access to training and resources as required.

RCSI has developed a Campus company policy to provide clarity and transparency for the development of start-ups.


RCSI has a number of successful start-up companies
SurgaColl Logo SurgaColl™ Technologies Ltd. has developed a range of regenerative technologies based on almost a decade of world class tissue engineering research carried out in the Royal College of Surgeons in Ireland (RCSI). The company's innovative product portfolio is based on a suite of common-platform technologies that offer regenerative solutions in the field of bone and cartilage/osteochondral tissue regeneration.
KelAda Pharmachem Logo KelAda Pharmachem was established in 2013 to acquire and develop intellectual assets in the pharmachemical space. The company’s model is to in-license and develop novel chemistry into scalable processes which can then be out-licensed to major pharmaceutical players. This development is done by a team of chemists with many combined years experience of chemical process development and manufacturing.


Additional information on external supports available for start-ups are listed below: